Corbus Pharmaceuticals Reports 2016 First Quarter Financial Results and Provides Business Update

Go back to Corbus Pharmaceuticals Reports 2016 First Quarter Financial Results and Provides Business Update

Corbus Pharma (CRBP) Misses Q1 EPS by 2c

May 16, 2016 8:14 AM EDT

Corbus Pharma (NASDAQ: CRBP) reported Q1 EPS of ($0.08), $0.02 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $396.6 thousand, versus $0 reported last year.

For earnings history and earnings-related data on Corbus Pharma (CRBP) click here.

... More